Introduction: Comorbidity between depression and diabetes is a particularly common condition as underdiagnosed. Individuals with diabetes have about a 2-fold increased risk for major depression, affecting one of every 10 diabetic patients. Biological and psychosocial variables represent risk factors. Comorbidity with depressive disorders led to a worsening of diabetic symptoms, greater functional impairment and worse quality of life. Objectives: To evaluate the relationship between depression and HbA1c levels, biological and sociodemographic factors, quality of life and diabetes distress. Aims: To demonstrate how depression in diabetic patients results in a worsening of clinical, treatment and social outcome. Methods: 72 patients with diabetes were recruited and matched into two groups (depressed, nondepressed). Socio-demographic data and HbA1c levels were collected. Diabetics patients were tested using Hamilton Depression Scale, Quality of Life Index and Diabetes Distress Scale (DDS). Results: Depressed diabetic patients had about a 4-fold increased risk for higher HbA1c levels (≥ 8%) (OD= 4.375). Depression was more prevalent in women than men (p < 0.05) and in retired (p < 0.05). Lower education level was significantly correlated with depression in comorbidity with diabetes (p < 0.05). Quality of life in depressive diabetic patients was poorer than patients without depression (p < 0.01). Depressed group showed higher levels in DDS particularly in Emotional Burden (p < 0.01), Regimen Distress (p < 0.01) and Interpersonal Distress (p < 0.05). Conclusions: Depression in diabetic patients is significantly related to biological and socio-demographic factors and worse quality of life. Depressed demonstrates higher distress due to diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.